{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:46:00Z","timestamp":1764783960785,"version":"3.41.0"},"reference-count":0,"publisher":"International Institute of Anticancer Research","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AR"],"published-print":{"date-parts":[[2017,5,7]]},"DOI":"10.21873\/anticanres.11613","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T18:11:54Z","timestamp":1494353514000},"page":"2655-2662","source":"Crossref","is-referenced-by-count":10,"title":["Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study"],"prefix":"10.21873","volume":"37","member":"9336","container-title":["Anticancer Research"],"original-title":[],"link":[{"URL":"http:\/\/ar.iiarjournals.org\/content\/37\/5\/2655.full.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T02:51:34Z","timestamp":1524019894000},"score":1,"resource":{"primary":{"URL":"http:\/\/ar.iiarjournals.org\/content\/37\/5\/2655.abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,7]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5,7]]}},"URL":"https:\/\/doi.org\/10.21873\/anticanres.11613","relation":{},"ISSN":["0250-7005","1791-7530"],"issn-type":[{"type":"print","value":"0250-7005"},{"type":"electronic","value":"1791-7530"}],"subject":[],"published":{"date-parts":[[2017,5,7]]}}}